NeuPath Health Inc.
NPTH.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 178.21% | -110.69% | 62.21% | -13.78% | -2.64% |
| Total Depreciation and Amortization | -6.13% | -3.88% | -4.08% | 2.67% | -3.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.33% | 15.67% | -18.02% | -19.69% | 32.50% |
| Change in Net Operating Assets | -259.27% | 227.59% | 226.25% | -1,536.74% | 310.01% |
| Cash from Operations | -115.16% | 59.79% | 127.60% | -106.68% | 1,374.73% |
| Capital Expenditure | -482.41% | 62.70% | -115.73% | 66.20% | 38.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -482.41% | 2.77% | -115.73% | 66.20% | 86.89% |
| Total Debt Issued | -- | 100.00% | -100.00% | -- | -- |
| Total Debt Repaid | 91.69% | -58.15% | -19.67% | 7.58% | -1,063.72% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 1.75% | -58.33% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.58% | -1,145.83% | 4.17% | 458.33% | -38.00% |
| Cash from Financing | -470.83% | -52.31% | -87.69% | 22.15% | 129.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -164.07% | 25.82% | 203.66% | -272.92% | 325.63% |